SEC Form 4 · accession 0001209191-15-004500
ACORDA THERAPEUTICS INC · ACOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John P Kelley
Director
Period of report
Jan 13, 2015
Accepted (ET)
Jan 15, 2015 · 6:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001008848
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 13, 2015 | M | 10,000 | $25.45 | A | 10,000 | D | |
| Common StockF1 | Jan 13, 2015 | S | 10,000 | $44.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Employee Stock OptionF1,F2 | $25.45 | Jan 13, 2015 | M | 10,000 | D | — | Jun 22, 2019 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1Exercise and sales pursuant to a 10b5-1 plan.
- F2The shares subject to this option vested in four equal quarterly installments over 12 months beginning June 22, 2009, with the first quarter fully vesting on September 22, 2009.